Skip to main content
Clinical Trials/NCT01645150
NCT01645150CompletedNot Applicable

Pilot Study on the Effects of Strength Training on Cancer Related Fatigue in Cancer Patients During Tyrosine Kinase Inhibitor Therapy

German Cancer Research Center1 site in 1 country20 target enrollmentStarted: May 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20
Locations
1
Primary Endpoint
Change in cancer related fatigue

Study Overview

Brief Summary

The purpose of this pilot study is to determine the effects of a 12-week resistance training program on cancer related fatigue in cancer patients receiving tyrosine kinase inhibitor (TKI) therapy. It is hypothesized that incidence and severity of cancer related fatigue can be reduced by exercise training in this population which leads to an improved treatment completion rate.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Male and female cancer patients
  • Prior to tyrosine kinase inhibitor therapy (any substance, any line)
  • Age: at least 18 yrs
  • Body mass index (BMI): at least 18 kg/m2
  • ECOG performance status: at most 2
  • Must be able to meet the requirements of the study protocol

Exclusion Criteria

  • Acute infectious diseases
  • No ambulatory ability
  • Severe neurological disorders
  • Severe cardiovascular diseases
  • Severe pulmonary insufficiency
  • Severe renal insufficiency
  • Other current tumor diseases
  • Conditions rendering compliance impossible
  • Participation in regular strength training

Arms & Interventions

Strength training group

Experimental

12 weeks of progressive strength training

Intervention: Progressive strength training (Behavioral)

Control group

No Intervention

No intervention

Outcomes

Primary Outcomes

Change in cancer related fatigue

Time Frame: From baseline to the 6th and 12th week of training.

Assessed via the Multidimensional Fatigue Inventory (MFI).

Secondary Outcomes

  • Change in muscle strength of the knee extensor, hip flexor and forearm flexor muscles.(From baseline to the 12th week of training.)
  • Change in body composition(From baseline to the 12th week of training)
  • Change in quality of life(From baseline to the 6th and 12th week of training.)
  • Change in endurance capacity(From baseline to the 12th week of training.)
  • Change in depression(From baseline to the 6th and 12th week of training.)
  • Time of the first tumor progression under TKI therapy(Within the first 6 months of TKI therapy)
  • Time of reduction or replacement of TKI therapy(Within the first 6 months of TKI therapy)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials